Midostaurin in Patients With AML and FLT3-TKD Mutations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Midostaurin in Patients With Acute Myeloid Leukemia and FLT3-TKD Mutations: A Subanalysis From the RATIFY Trial
Blood Adv 2020 Oct 13;4(19)4945-4954, MT Voso, RA Larson, D Jones, G Marcucci, T Prior, J Krauter, M Heuser, S Lavorgna, J Nomdedeu, SM Geyer, A Walker, AH Wei, J Sierra, MA Sanz, JM Brandwein, TM de Witte, JH Jansen, D Niederwieser, FR Appelbaum, BC Medeiros, MS Tallman, RF Schlenk, A Ganser, S Amadori, Y Cheng, Y Chen, C Pallaud, L Du, A Piciocchi, G Ehninger, J Byrd, C Thiede, K Döhner, RM Stone, H Döhner, CD Bloomfield, F Lo-CocoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.